Health
Philips beats second-quarter forecasts thanks to cost savings and insurance payments
Philips on Monday reported second-quarter results that beat analysts’ expectations, helped by cost savings from job cuts and insurance gains related to Respironics product liability
GSK settles another heartburn drug lawsuit in Illinois
British drugmaker GSK said Monday it has agreed to confidentially settle an Illinois lawsuit alleging that the discontinued heartburn drug Zantac causes cancer. It is
Drug maker Sinergium will share bird flu vaccine data globally
The World Health Organisation said on Monday that bird flu vaccine developer Sinergium Biotech will share its data with manufacturers in low- and middle-income countries
Abbott must pay $495 million in preemie formula lawsuit
A jury found that a specialised formula for premature babies from Abbott Laboratories caused an Illinois girl to develop a dangerous intestinal disease, and ordered
EU regulator backs GSK’s rubella virus vaccine for use in adults aged 50-59 years
The European Union’s health regulator has recommended expanding the use of GSK’s respiratory syncytial virus (RSV) vaccine to adults aged 50-59 years. The vaccine, called
EU approves $2.2 billion in Dutch state aid for medical isotopes for cancer treatment
The Netherlands won EU approval for 2 billion euros in state aid to build a nuclear reactor to produce medical isotopes for cancer treatment. The
UK regulator authorises updated Pfizer-BioNTech COVID vaccine
Britain’s health regulator said on Wednesday it has granted approval to Pfizer and BioNTech’s updated COVID-19 vaccine targeting the JN.1 subspecies for use in infants,
Pfizer gene therapy reduces bleeding rates in haemophilia A in late-stage study
Pfizer the company reported that a gene therapy for haemophilia A significantly reduced the number of annual bleeding episodes in patients with the rare disease
Roche raises 2024 profit forecast due to strong drug sales
Roche on Thursday raised its full-year profit forecast after beating expectations for the first half of the year, driven by strong demand for new drugs
Children at risk as mpox arrives in Congolese IDP camps
Local doctors say they have seen 130 suspected cases of mpox, almost all in children and adolescents, in the past four weeks at a nearby